TY - JOUR
AU - Agrawal, Utkarsh
AU - Bedston, Stuart
AU - McCowan, Colin
AU - Oke, Jason
AU - Patterson, Lynsey
AU - Robertson, Chris
AU - Akbari, Ashley
AU - Azcoaga-Lorenzo, Amaya
AU - Bradley, Declan T.
AU - Fagbamigbe, Adeniyi F.
AU - Grange, Zoe
AU - Hall, Elliott
AU - Joy, Mark
AU - Katikireddi, Srinivasa Vittal
AU - Kerr, Steven
AU - Ritchie, Lewis
AU - Murphy, Siobhán
AU - Owen, Rhiannon K.
AU - Rudan, Igor
AU - Shah, Syed Ahmar
AU - Simpson, Colin R
AU - Torabi, Fatemeh
AU - Tsang, Ruby S M
AU - de Lusignan, Simon
AU - Lyons, Ronan A.
AU - O'Reilly, Dermot
AU - Sheikh, Aziz
PY - 2022
DA - October
TI - Severe COVID-19 outcomes after full vaccination of primary schedule and initial boosters: pooled analysis of national prospective cohort studies of 30 million individuals in England, Northern Ireland, Scotland, and Wales
JO - The Lancet
EP - 1320
VL - 400
IS - 10360
DO - https://doi.org/10.1016/S0140-6736
AB - Current UK vaccination policy is to offer future COVID-19 booster doses to individuals at high risk of serious illness from COVID-19, but it is still uncertain which groups of the population could benefit most. In response to an urgent request from the UK Joint Committee on Vaccination and Immunisation, we aimed to identify risk factors for severe COVID-19 outcomes (ie, COVID-19-related hospitalisation or death) in individuals who had completed their primary COVID-19 vaccination schedule and had received the first booster vaccine.
PB - Elsevier
UR - https://hdl.handle.net/2164/19379
KW - Coronavirus (COVID-19)
KW - Immunisation and screening
ER